Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. [electronic resource]
- Neurobiology of aging Sep 2012
- 2062-71 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1558-1497
10.1016/j.neurobiolaging.2011.08.015 doi
Aging--blood Alzheimer Disease--drug therapy Analysis of Variance Animals Biological Availability Brain--drug effects Dietary Supplements Disease Models, Animal Female Gas Chromatography-Mass Spectrometry Gene Expression Regulation--drug effects MAP Kinase Kinase 4--metabolism Male Maze Learning--drug effects Mice Neurotransmitter Agents--administration & dosage PPAR alpha--metabolism Phosphorylation--drug effects Protein Serine-Threonine Kinases--metabolism Resveratrol Signal Transduction--drug effects Sirtuin 1--genetics Stilbenes--administration & dosage tau Proteins--metabolism NF-kappaB-Inducing Kinase